Onitilo et al developed a score for staging a differentiated thyroid carcinoma. This is meant to be simpler to determine than the TNM stage. The authors are from Karolinska University Hospital, Mubarak Al-Kabeer Teaching Hospital and Kuwait University.
Patient selection: differentiated thyroid cancer
Parameters:
(1) histologic type
(2) age of the patient in years
(3) number of regional lymph nodes with metastases
(4) tumor diameter and/or extrathyroid extension
|
Parameter |
Finding |
Points |
|
histologic type |
papillary |
0 |
|
|
nonpapillary |
1 |
|
age of the patient in years |
< 45 years of age |
0 |
|
|
>= 45 years of age |
4 |
|
number of lymph node metastases |
0 |
0 |
|
|
>= 1 |
4 |
|
tumor features |
limited to thyroid and <= 4 cm in diameter |
0 |
|
|
limited to thyroid and > 4 cm in diameter |
6 |
|
|
any extrathyroid extension |
6 |
total score =
= SUM(points for all 4 parameters)
Interpretation:
• minimum score: 0
• maximum score: 15
• The higher the score the greater the risk.
|
Total Score |
Risk Group |
Stage |
10 Year Cancer Specific Survival |
|
0 to 5 |
low |
1 |
100% |
|
6 to 10 |
intermediate |
2 |
90% |
|
11 to 15 |
high |
3 |
65% |
Specialty: Hematology Oncology, Surgery, general, Endocrinology
